|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1994-1-31
|
|
pubmed:abstractText |
Interferons have shown a definite activity in the intravesical treatment of residual papillary bladder cancer or carcinoma in situ (CIS). The purpose of the present study was to investigate the efficacy of interferon alfa-2b (IFN) as prophylactic treatment of superficial bladder cancer.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
7-13
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8270987-Administration, Intravesical,
pubmed-meshheading:8270987-Adult,
pubmed-meshheading:8270987-Aged,
pubmed-meshheading:8270987-Aged, 80 and over,
pubmed-meshheading:8270987-Carcinoma, Papillary,
pubmed-meshheading:8270987-Carcinoma in Situ,
pubmed-meshheading:8270987-Cystoscopy,
pubmed-meshheading:8270987-Drug Administration Schedule,
pubmed-meshheading:8270987-Female,
pubmed-meshheading:8270987-Humans,
pubmed-meshheading:8270987-Interferon-alpha,
pubmed-meshheading:8270987-Male,
pubmed-meshheading:8270987-Middle Aged,
pubmed-meshheading:8270987-Mitomycin,
pubmed-meshheading:8270987-Neoplasm Recurrence, Local,
pubmed-meshheading:8270987-Recombinant Proteins,
pubmed-meshheading:8270987-Statistics as Topic,
pubmed-meshheading:8270987-Treatment Outcome,
pubmed-meshheading:8270987-Urinary Bladder Neoplasms
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study.
|
|
pubmed:affiliation |
Department of Medical Oncology II, National Institute for Cancer Research, Genova, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
